131 related articles for article (PubMed ID: 36972240)
1. Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection.
Yang X; Zhao L; Shi A; Chen C; Cao J; Zhang Y; Zhu H; Wang J; Zhou W; Li X; Hu S; Men Y; Wang J; Xue L; Liu Y; Dou L; Zhang Y; Sun S; Yuan M; Bao Y; Ma Z; Liu Y; Zhang W; Bi N; Wang G; Hui Z
Am J Gastroenterol; 2023 Aug; 118(8):1344-1352. PubMed ID: 36972240
[TBL] [Abstract][Full Text] [Related]
2. Additional radiotherapy following endoscopic submucosal dissection for T1a-MM/T1b-SM esophageal squamous cell carcinoma improves locoregional control.
Hisano O; Nonoshita T; Hirata H; Sasaki T; Watanabe H; Wakiyama H; Ono M; Ohga S; Honda H
Radiat Oncol; 2018 Jan; 13(1):14. PubMed ID: 29378603
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S; Hatta W; Watanabe K; Koike T; Shimada T; Hikichi T; Toya Y; Tanaka I; Onozato Y; Hamada K; Fukushi D; Watanabe K; Kayaba S; Ito H; Mikami T; Oikawa T; Takahashi Y; Kondo Y; Yoshimura T; Shiroki T; Nagino K; Hanabata N; Funakubo A; Hirasawa D; Ohira T; Nakamura J; Nakamura T; Nakaya N; Matsumoto T; Fukuda S; Masamune A; Iijima K
Dig Dis Sci; 2023 May; 68(5):2050-2060. PubMed ID: 36445654
[TBL] [Abstract][Full Text] [Related]
4. Impact of the Charlson Comorbidity Index on the treatment strategy and survival in elderly patients after non-curative endoscopic submucosal dissection for esophageal squamous cell carcinoma: a multicenter retrospective study.
Nakajo K; Abe S; Oda I; Ishihara R; Tanaka M; Yoshio T; Katada C; Yano T
J Gastroenterol; 2019 Oct; 54(10):871-880. PubMed ID: 31055660
[TBL] [Abstract][Full Text] [Related]
5. A retrospective cohort study to observe the efficacy and safety of Endoscopic Submucosal Dissection (ESD) with adjuvant radiotherapy for T1a-MM/T1b-SM Esophageal Squamous Cell Carcinoma (ESCC).
Lu H; Bei Y; Wang C; Deng X; Hu Q; Guo W; Zhang X
PLoS One; 2024; 19(2):e0298792. PubMed ID: 38386660
[TBL] [Abstract][Full Text] [Related]
6. Management decision based on lymphovascular involvement leads to favorable outcomes after endoscopic treatment of esophageal squamous cell carcinoma.
Takahashi K; Hashimoto S; Mizuno KI; Kobayashi T; Tominaga K; Sato H; Kohisa J; Ikarashi S; Hayashi K; Takeuchi M; Yokoyama J; Kawai H; Sato Y; Kobayashi M; Terai S
Endoscopy; 2018 Jul; 50(7):662-670. PubMed ID: 29272907
[TBL] [Abstract][Full Text] [Related]
7. [Efficacy and safety of endoscopic submucosal dissection with additional radiotherapy for T1a-MM/T1b-SM esophageal squamous cell carcinoma].
Chen YF; Liu SQ; Li MY; Chen R; Shi RH
Zhonghua Yi Xue Za Zhi; 2023 Dec; 103(45):3676-3682. PubMed ID: 38018068
[No Abstract] [Full Text] [Related]
8. Influence of Lymphangio vascular (V) and perineural (N) invasion on survival of patients with resected esophageal squamous cell carcinoma (ESCC): a single-center retrospective study.
Xie C; Chen Z; Xu J; Meng Z; Huang Z; Lin J
PeerJ; 2022; 10():e12974. PubMed ID: 35256918
[TBL] [Abstract][Full Text] [Related]
9. Clinical Outcomes of Follow-Up Observation After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma Invading the Muscularis Mucosa Without Lymphovascular Involvement.
Iwai N; Dohi O; Yamada S; Ishida T; Fukui A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Yagi N; Naito Y; Itoh Y
Dig Dis Sci; 2023 Sep; 68(9):3679-3687. PubMed ID: 37470897
[TBL] [Abstract][Full Text] [Related]
10. Endoscopic submucosal dissection with additional radiotherapy in the treatment of T1a esophageal squamous cell cancer: randomized controlled Trial.
Zhang Y; Liu L; Wang Q; Guo L; Ye L; Zeng H; Zeng X; Yuan X; Li Y; Zhang Y; Zhou E; Hu B
Endoscopy; 2020 Dec; 52(12):1066-1074. PubMed ID: 32668474
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of lymphovascular invasion in patients with pT1b esophageal squamous cell carcinoma.
Liu L; Lin H; Shen G; Liu Y; Qin X; Yuan Y; Wang B; Xue L
BMC Cancer; 2023 Apr; 23(1):370. PubMed ID: 37087442
[TBL] [Abstract][Full Text] [Related]
12. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma.
Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT
Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575
[TBL] [Abstract][Full Text] [Related]
13. The efficacy of additional surgical resection after endoscopic resection in pT1b esophageal squamous cell carcinoma: A multi-institutional retrospective study in China.
Xue X; Sun Q; Jiang D; Wang X; Liu Y; Guo C; Liu L; Cheng N; Wang G; Liu Y; Hou Y; Fan X; Xue L
Surg Endosc; 2023 Feb; 37(2):871-880. PubMed ID: 36008639
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T; Sato D; Inaba A; Nishihara K; Takashima K; Nakajo K; Yukami H; Mishima S; Sawada K; Kotani D; Fujiwara H; Nakamura M; Hojo H; Yoda Y; Kojima T; Fujita T; Yano T
Esophagus; 2022 Jan; 19(1):153-162. PubMed ID: 34420139
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Endoscopic Submucosal Dissection vs Esophagectomy for T1 Esophageal Squamous Cell Carcinoma in a Real-World Cohort.
Zhang Y; Ding H; Chen T; Zhang X; Chen WF; Li Q; Yao L; Korrapati P; Jin XJ; Zhang YX; Xu MD; Zhou PH
Clin Gastroenterol Hepatol; 2019 Jan; 17(1):73-81.e3. PubMed ID: 29704682
[TBL] [Abstract][Full Text] [Related]
16. Prognostic risk factors associated with esophageal squamous cell carcinoma patients undergoing endoscopic submucosal dissection: a multi-center cohort study.
Iwai N; Dohi O; Yamada S; Harusato A; Horie R; Yasuda T; Yamada N; Horii Y; Majima A; Zen K; Kimura H; Yagi N; Naito Y; Itoh Y
Surg Endosc; 2022 Apr; 36(4):2279-2289. PubMed ID: 33860352
[TBL] [Abstract][Full Text] [Related]
17. Esophagectomy versus definitive chemoradiotherapy for patients with clinical stage N0 and pathological stage T1b esophageal squamous cell carcinoma after endoscopic submucosal dissection: study protocol for a multicenter randomized controlled trial (Ad-ESD Trial).
Yang Y; Su Y; Zhang X; Liu J; Zhang H; Li B; Hua R; Tan L; Chen H; Li Z
Trials; 2020 Jul; 21(1):603. PubMed ID: 32611448
[TBL] [Abstract][Full Text] [Related]
18. Comparison of long-term outcomes between esophagectomy and chemoradiotherapy after endoscopic resection of submucosal esophageal squamous cell carcinoma.
Tanaka T; Ueno M; Iizuka T; Hoteya S; Haruta S; Udagawa H
Dis Esophagus; 2019 Dec; 32(12):. PubMed ID: 30980070
[TBL] [Abstract][Full Text] [Related]
19. Feasibility of Endoscopic Submucosal Dissection for Early Esophageal Squamous Cell Carcinoma with Relative Indications.
Liu Y; Qian D; Tang B; Fan C; Yu J; Lin H; Bai J; Zhao X
Dig Surg; 2021; 38(1):14-23. PubMed ID: 33271540
[TBL] [Abstract][Full Text] [Related]
20. Adjuvant therapy for pT1a-m3/pT1b esophageal squamous cell carcinoma after endoscopic resection: Esophagectomy or chemoradiotherapy? A critical review.
Tsou YK; Lee CH; Le PH; Chen BH
Crit Rev Oncol Hematol; 2020 Mar; 147():102883. PubMed ID: 32014674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
